Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
Navneet SinghSarah TeminSherman BakerElizabeth BlanchardJulie R BrahmerPaul CelanoNarjust FlorezPeter M EllisIvy B ElkinsRami Y HaddadPaul J HeskethDharamvir JainDavid H JohnsonNatasha B LeighlHirva MamdaniGregory A MastersPamela R MoffittTanyanika PhillipsGregory J RielyNicholas G ZaorskyRafael RosellJoan H SchillerBryan J SchneiderDavid R SpigelIshmael A JaiyesimiPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
rearrangement who have not received RET-targeted therapy, clinicians may offer selpercatinib or pralsetinib.Additional information is available at www.asco.org/thoracic-cancer-guidelines.